402
Views
23
CrossRef citations to date
0
Altmetric
Research Article

Nanocrystal-based drug delivery system of risperidone: lyophilization and characterization

, & ORCID Icon
Pages 1458-1466 | Received 22 Nov 2017, Accepted 28 Mar 2018, Published online: 11 Apr 2018
 

Abstract

Objective: In the present work nanocrystal-based formulation of risperidone (RIS) was proposed to overcome solubility issue of RIS, while lyophilization technique was used effectively, for conversion of RIS nanosuspension to solid state.

Significance: RIS nanosuspension was developed and stabilized with a combination of polycaprolactone and Pluronic® F-68 as stabilizers. With focus on critical parameters like nature of cryoprotectants and effect of eutectic temperature on properties of nanosuspension, the suitability of lyophilization technique in improving the physical stability of prepared nanosuspension was also evaluated. Additionally, the developed nanocrystals were also assessed for their solid states properties.

Methods: Various process parameters affecting average particle size and polydispersity index (PDI), viz. drug to surfactant ratio, solvent to anti-solvent ratio, stirring speed, type of stabilizer were optimized. Assessment of lyophilization as a suitable solidification technique (for conversion to powder form) was done with selective cryoprotectants (trehalose dihydrate and sorbitol).

Results: The formulation was found to be stable at 4 °C for 3 months with size, PDI and zeta potential of 214 ± 3.4 nm, 0.120, and –10.2 ± 0.90 mV, respectively. Release profile of developed nanosuspension showed cumulative % release of ∼90% in initial 10 h whereas the value for the unprocessed drug was ∼11% in same time frame.

Conclusions: These findings suggest that developed formulation was able to enhance water solubility of the drug effectively and can be potentially used in the management of psychotic disorders.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Additional information

Funding

This research work was supported by National Institute of Pharmaceutical Education and Research (NIPER)-Ahmedabad under the financial support of Ministry of Chemicals and Fertilizers, DST INSPIRE LSBM-13 and SERB EMR/2016/007966, India.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.